M&A / Deals AstraZeneca, GSK intensify China ties with Sino Biopharm deals BioPharma DiveThe U.K.Read full story pharminent July 8, 2026 (Last updated: July 9, 2026) BioPharma Dive The U.K. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: AstraZeneca bets up to $1.9B in respiratory disease collab with Sino BiopharmaceuticalNext: Tanabe pens deal to sell plants to Towa in post-buyout pivot Related Stories M&A / Deals J&J ventures further into in vivo CAR-T space with Sail partnership, potential buyout pharminent July 31, 2026 M&A / Deals Eisai and CORE Biomedicine agree on global licence for oncology pipeline pharminent July 29, 2026 M&A / Deals Argenx signs agreement to buy Forte Biosciences for $2.2bn pharminent July 28, 2026
